Skip to content

DECATHLON TWIN LUMEN HEMODIALYSIS WITH SEPARATED TIPS - 36SH

by Spire Biomedical, Inc.

510(k) K032061

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None ongoing

48 closed

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESK Substantially Equivalent — Kit · Traditional NumberK032061 Date23 Dec 2003ClearedStatusActive

Recalls

48 recalls · FDA

  • 48 recalls, same reason

    • Terminated Z-0331-2010 FDA Unclassified (pre-2012) initiated 23 Oct 2009
    • Terminated Z-0335-2010 FDA Unclassified (pre-2012) initiated 23 Oct 2009
    • Terminated Z-0304-2010 FDA Unclassified (pre-2012) initiated 23 Oct 2009
    • Terminated Z-0292-2010 FDA Unclassified (pre-2012) initiated 23 Oct 2009
    • Terminated Z-0324-2010 FDA Unclassified (pre-2012) initiated 23 Oct 2009
    • Terminated Z-0314-2010 FDA Unclassified (pre-2012) initiated 23 Oct 2009
    • Terminated Z-0329-2010 FDA Unclassified (pre-2012) initiated 23 Oct 2009
    • Terminated Z-0334-2010 FDA Unclassified (pre-2012) initiated 23 Oct 2009
    • Terminated Z-0307-2010 FDA Unclassified (pre-2012) initiated 23 Oct 2009
    • Terminated Z-0298-2010 FDA Unclassified (pre-2012) initiated 23 Oct 2009
    • Terminated Z-0300-2010 FDA Unclassified (pre-2012) initiated 23 Oct 2009
    • Terminated Z-0333-2010 FDA Unclassified (pre-2012) initiated 23 Oct 2009
    • Terminated Z-0289-2010 FDA Unclassified (pre-2012) initiated 23 Oct 2009
    • Terminated Z-0327-2010 FDA Unclassified (pre-2012) initiated 23 Oct 2009
    • Terminated Z-0312-2010 FDA Unclassified (pre-2012) initiated 23 Oct 2009
    • Terminated Z-0297-2010 FDA Unclassified (pre-2012) initiated 23 Oct 2009
    • Terminated Z-0301-2010 FDA Unclassified (pre-2012) initiated 23 Oct 2009
    • Terminated Z-0322-2010 FDA Unclassified (pre-2012) initiated 23 Oct 2009
    • Terminated Z-0323-2010 FDA Unclassified (pre-2012) initiated 23 Oct 2009
    • Terminated Z-0293-2010 FDA Unclassified (pre-2012) initiated 23 Oct 2009
    • Terminated Z-0321-2010 FDA Unclassified (pre-2012) initiated 23 Oct 2009
    • Terminated Z-0317-2010 FDA Unclassified (pre-2012) initiated 23 Oct 2009
    • Terminated Z-0310-2010 FDA Unclassified (pre-2012) initiated 23 Oct 2009
    • Terminated Z-0302-2010 FDA Unclassified (pre-2012) initiated 23 Oct 2009
    • Terminated Z-0325-2010 FDA Unclassified (pre-2012) initiated 23 Oct 2009
    • Terminated Z-0295-2010 FDA Unclassified (pre-2012) initiated 23 Oct 2009
    • Terminated Z-0291-2010 FDA Unclassified (pre-2012) initiated 23 Oct 2009
    • Terminated Z-0303-2010 FDA Unclassified (pre-2012) initiated 23 Oct 2009
    • Terminated Z-0315-2010 FDA Unclassified (pre-2012) initiated 23 Oct 2009
    • Terminated Z-0313-2010 FDA Unclassified (pre-2012) initiated 23 Oct 2009
    • Terminated Z-0318-2010 FDA Unclassified (pre-2012) initiated 23 Oct 2009
    • Terminated Z-0290-2010 FDA Unclassified (pre-2012) initiated 23 Oct 2009
    • Terminated Z-0294-2010 FDA Unclassified (pre-2012) initiated 23 Oct 2009
    • Terminated Z-0326-2010 FDA Unclassified (pre-2012) initiated 23 Oct 2009
    • Terminated Z-0305-2010 FDA Unclassified (pre-2012) initiated 23 Oct 2009
    • Terminated Z-0288-2010 FDA Unclassified (pre-2012) initiated 23 Oct 2009
    • Terminated Z-0332-2010 FDA Unclassified (pre-2012) initiated 23 Oct 2009
    • Terminated Z-0320-2010 FDA Unclassified (pre-2012) initiated 23 Oct 2009
    • Terminated Z-0299-2010 FDA Unclassified (pre-2012) initiated 23 Oct 2009
    • Terminated Z-0296-2010 FDA Unclassified (pre-2012) initiated 23 Oct 2009
    • Terminated Z-0328-2010 FDA Unclassified (pre-2012) initiated 23 Oct 2009
    • Terminated Z-0319-2010 FDA Unclassified (pre-2012) initiated 23 Oct 2009
    • Terminated Z-0316-2010 FDA Unclassified (pre-2012) initiated 23 Oct 2009
    • Terminated Z-0330-2010 FDA Unclassified (pre-2012) initiated 23 Oct 2009
    • Terminated Z-0309-2010 FDA Unclassified (pre-2012) initiated 23 Oct 2009
    • Terminated Z-0308-2010 FDA Unclassified (pre-2012) initiated 23 Oct 2009
    • Terminated Z-0306-2010 FDA Unclassified (pre-2012) initiated 23 Oct 2009
    • Terminated Z-0311-2010 FDA Unclassified (pre-2012) initiated 23 Oct 2009

    There is a possibility that the catheter tubing could separate from the hub/bifurcation of the device. If this occurs, bleeding is the primary clinical complication likely to result from catheter tubing/hub separation. A second potential clinical complication is air embolism, particularly for the segment of the patient population that develops negative central venous pressure during normal respira

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA Product Code
MSD
Models / Variants
36SH
Device Class
Class II
Regulation
21 CFR Part 876.5540
Advisory Committee
Gastroenterology, Urology
FDA Decision
SESK Substantially Equivalent — Kit

Other devices from Spire Biomedical, Inc.

See all devices from Spire Biomedical, Inc. →